Your address will show here +12 34 56 78
The Future of
Health Innovation

Aevolve is a powerful channel for bringing medical innovations to their next stages of development, so patients benefit from a new world of solutions.
Watch Video
Introducing the newest partner in advancing medical solutions: You.
Health innovation reinvented to increase yield and opportunity for all.
Medical innovation has been in a state of crisis in recent decades. The overall productivity rate for the entire biopharma industry has been in steady decline. While scientists, doctors and biotech innovators around the world remain committed in the search of new answers that could potentially change lives and offer solutions to the world’s deadliest diseases, the path from scientific discovery to commercial availability is a long, compliance-ridden and resource-intensive journey.

Today, large amounts of capital are still being channeled into biopharma R&D, but outcomes of such projects remain unpredictable. The process relies on trial and error with very few predictors of successful commercialization. This creates a climate of increased risk for investors.

Rising costs are also a contributor to the industry’s declining productivity. They limit the potential of capital to spur innovation. Out-of-pocket costs for drug development have been escalating in recent years. Alongside high failure rates in the testing process and low clinical success rates, the entire model simply isn’t sustainable enough to accelerate the development of new treatments and cures in the coming decades. It is low-yield for investors and innovators, and low-access for patients.

The business model of health innovation needs reinvention. The health system of the future needs to evolve into one that optimizes available capital, harnesses new sources of funding, allows new participants, eases payer pressure, increases yield and expands opportunity for all.

Aevolve reimagines the medical innovation pathway by creating a new protocol that bridges the gaps in funding and optimizes opportunity by diversifying capital sources. This new model opens up the innovation space to more small cap players and more R&D projects. This is facilitated through the application of new financial technology, securitization channels and bridge protocols that increase interaction among stakeholders.

More importantly, through blockchain technology and new participation methods, patients are empowered to make their own decisions and steer the health industry into one with greater diversity and better-aligned incentives.
%
UNFUNDED RESEARCH APPLICATIONS

Eighty-five percent of medical research applications submitted to governments globally go unfunded. Many innovations die due to lack of capital. They may have saved many lives.

B
BIOTECHNOLOGY MARKET

The global biotechnology market is expected to reach USD 727.1 billion by 2025.

M
100 M DOLLAR OFFERING

The first new digital token launch through a tradable Structured Product security (AVEX.AI) on the Six (Swiss Stock Exchange).

B
OVER 1 BILLION DOLLARS IN  PRODUCT OFFERINGS 

The BIOSPHERES platform will launch with over USD 1 billion worth of medical solutions offerings that address major diseases like Alzheimer’s and ALS.

THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
About Aevolve

Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.

INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
AVEX.AI

This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.

FOR PATIENTS AND INNOVATORS
BIOSPHERES

This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.

BLOCKCHAIN TOOLS
AVEX Token & The Aevolve Protocol

Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.

We are hiring

Are you looking for job?

We are a fairly small, flexible design studio that designs for print and web. We work flexibly with Send us your resume & portfolio